BFG
TXMD icon

Baron Financial Group’s TherapeuticsMD TXMD Stock Holding History

Baron Financial Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16
Closed -$304 – 217
2022
Q1 		$304 Hold
16
– – ﹤0.01% 217
2021
Q4 		$284 Hold
16
– – ﹤0.01% 220
2021
Q3 		$593 Hold
16
– – ﹤0.01% 222
2021
Q2 		$952 Hold
16
– – ﹤0.01% 230
2021
Q1 		$1.07K Hold
16
– – ﹤0.01% 229
2020
Q4 		$968 Hold
16
– – ﹤0.01% 241
2020
Q3 		$1.26K Buy
+16
New +$1.27K ﹤0.01% 250

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Baron Financial Group's TXMD Position: Q2 2022 in Review

Baron Financial Group sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 16 shares — an estimated $304 sold.

Baron Financial Group first reported a position in TXMD in Q3 2020 and held it in 7 quarters. The position peaked at $1.26K in Q3 2020. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Baron Financial Group reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Baron Financial Group sold 16 TherapeuticsMD shares in Q2 2022, an estimated $304.
  • Baron Financial Group first reported a position in TherapeuticsMD in Q3 2020 and held it in 7 quarters.
  • Baron Financial Group's TherapeuticsMD position peaked at $1.26K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Baron Financial Group's 13F filing for Q2 2022, filed 11 Aug 2022.